Healthy Extracts Inc. (HYEX)
HYEX is quoted over the counter, not listed on an exchange. Healthy Extracts Inc. files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.
Closes: Yahoo Finance daily closes, last bar 2026-11-13.
Profile
| Field | Value |
|---|---|
| Ticker | HYEX, quoted over the counter |
| SEC CIK | 0001630176 |
| OTC Markets tier | OTCQB (price source, 2026-11-13) |
| SEC industry code | Medicinal Chemicals & Botanical Products |
| Business address | Henderson, NV |
| Incorporated in | NV |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | States substantial doubt about continuing as a going concern. "Management plans to keep seeking funding through debt and equity financing which are intended to mitigate the conditions that have raise substantial doubt about the entity's ability to continue as a going concern." | 10-Q 2026-08-14 |
| Cash and burn | $190K cash; operating cash flow $125K a quarter. | Report 2026-06-30 |
| Shares outstanding | 14,741,348 (2026-08-14); 16,870,868 a year earlier; 345,492,442 three years earlier. 3y figure adjusted for splits (1-for-120 overall). | Cover page 2026-08-14 |
| Reverse splits, 3 years | 1; latest 1-for-120 on 2023-12-29 | Source 2023-12-29 |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | Bush & Associates CPA LLC, Las Vegas, Nevada, United States | PCAOB Form AP 2026-04-13 |
| Late filings, 12 months | 1 NT notice | NT 10-K 2026-04-01 |
| Insider trades, 12 months | Bought $0, sold $0 on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q2 2026 2026-06-30 | $2.1M | -$129K | $306K | $190K | $928K | $6.3M | 10-Q 2026-08-14 |
| Q1 2026 2026-03-31 | $1.6M | -$201K | $106K | $164K | $1.3M | $5.2M | 10-Q 2026-05-14 |
| Q4 2025 2025-12-31 | $1.7M | -$154K | $368K | $147K | $111K | $4.5M | 10-K 2026-04-09 |
| Q3 2025 2025-09-30 | $918K | -$395K | -$280K | $189K | $288K | $3.6M | 10-Q 2025-11-14 |
| Q2 2025 2025-06-30 | $969K | $67K | $17K | $200K | $643K | $3.4M | 10-Q 2026-08-14 |
| Q1 2025 2025-03-31 | $931K | -$399K | $60K | $119K | $494K | $3.4M | 10-Q 2026-05-14 |
| Q4 2024 2024-12-31 | $771K | -$447K | $42K | $112K | $533K | $3.1M | 10-K 2026-04-09 |
| Q3 2024 2024-09-30 | $745K | $354K | $52K | $100K | $721K | $3.0M | 10-Q 2025-11-14 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-1/A | 2023-11-22 |
| Latest annual report | 10-K | 2026-04-09 |
| Latest quarterly / interim | 10-Q | 2026-11-16 |
| Latest current report | 8-K | 2026-09-18 |
| Latest proxy | DEF 14A | 2018-02-28 |
Source: SEC EDGAR submissions feed, 196 recent filings. All filings on EDGAR.
The full dossier has every filing, quarterly and annual financials, the health record and a price chart.
Open the full dossier